… tumour organoids (PDOs) have revolutionised our understanding of cancer biology and
the applications of personalised therapies… characteristics of parental tumours. Given these …

… for studying cancer and directing personalised therapies. This review aims to highlight how
… Our ability to manipulate tumour organoids further improves the utility of this culture system in …

… Tumour organoids are promising models for personalised medicine in the context of …
Reporting in vitro response of patient-derived tumour organoids to therapeutic agents in a way that …

… normal and tumour organoids (PDO) and used to assess radiation responses. Such organoid
… allow assessment of personalised therapeutic ratio and prediction of treatment response [ …

… therapies to circumvent the frequent emergence of tumour … personalised oncology (FPO)
approach in identifying tumour vulnerabilities by observing the phenotypic changes in tumour …

… cancer organoids/tumouroids can more faithfully mimic the tumour in … highly personalised
in vitro model that replicates the tumour … , and responsiveness to therapy in vivo, essentially …

… -derived xenograft and organoid models of … to therapy of the human tumours they originated
from. In this review, we discuss the development of patient-derived xenograft and organoid …

… However, these techniques also have a high potential to offer personalised therapies to …
between parental tumours and corresponding organoid (Ref. 60). However, organoids can also …

… To identify potential targeted therapeutic molecules in the patients' primary tumours, we
performed WES of six biliary tumours from which cancer organoids were obtained. We selected …

… tissue and tumour-derived organoids allow the screening of therapeutic agents … tumour-reactive
lymphocytes in a personalised manner. Their work revealed that tumour organoids …